Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 2, 2008

View Archived Issues

Further clinical study of MK-7009 to follow evaluation in healthy volunteers

Anti-HCV activity of R-7128 seen in different races/ethnicities

Takeda updates key milestones of first half of 2008

Novel dual CB1/CB2 receptor agonist efficacious in experimental pain models

Helsinn Healthcare and Zealand Pharma partner for ZP-1846

ProStrakan grants license to Bayer Schering for Tostran testosterone treatment

Prana provides update on research and development programs

GFT-505 shows beneficial effect on plasma lipids

Novel agents for cardiovascular disorders disclosed in recent CTG Pharma patent

Streptococcal endopeptidase IdeS prevents experimental glomerulonephritis

Recent patents describe new treatment options for thrombotic disorders

ONO-1301MS may improve tubulointerstitial injury in chronic kidney disease

Novel antiinflammatory agents jointly claimed by Boehringer Ingelheim and Biolipox

Phase II chronic plaque psoriasis study with ALT-2074 currently enrolling patients

Positive results reported for novel HDAC inhibitor in experimental Huntington's disease in mice

Ark files MAA with EMEA for Cerepro for malignant glioma

FDA accepts Cell Therapeutics' Zevalin sBLA and grants priority review

FDA approves Duramed's synthetic conjugated estrogens-A cream

Quintiles acquires Targeted Molecular Diagnostics

Lexicon files IND with the FDA for LX-4211 as a potential treatment for diabetes

Paladin and GSK sign 3-year distribution agreement for Dexedrine for ADHD

TorreyPines reports results from study of NGX-426 in capsaicin-induced pain

ANA-598 receives FDA fast track designation for chronic hepatitis C infection

FDA grants orphan drug designation to pralatrexate for follicular lymphoma

ViroPharma submits sBLA for Cinryze for hereditary angioedema

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...